US Naproxen Prices Firm 2% in January amid Inventory Tightness

US Naproxen Prices Firm 2% in January amid Inventory Tightness

Ivan Turgenev 02-Feb-2026

The value of Naproxen has increased in the US import market in the first month of 2026. The price of Naproxen has increased in January which was driven by the upward movement of the prices across the supply chain. The price increase in the US has mirrored the price trend of the Chinese export market. The market has observed a period of procurement urgency, inventory management and disciplined supplier prices. The downstream pharmaceutical manufacturers in the US have entered the new production cycles in January. The buyers have reassessed their stock position and identified the inventory gaps that were created by conservative procurement in the previous cycle. The tight inventory levels have prompted the procurers to secure Naproxen early in the first quarter. The market increase in January was demand led as the buyers have prioritized supply security over price sensitivity. The market insights of ChemAnalyst and their forecast analysis will help the market participants of Naproxen to mitigate volatility and maximize their opportunities when costs soften.

Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility. Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
Tags:

Naproxen

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.